GGrantIndex
← Search

FACS (Flow Cytometry)

$112,306P30FY2021CANIH

Albert Einstein College Of Medicine, Bronx NY

Investigators

Linked publications, trials & patents

Paper 39499645Paper 39392861Paper 39378878Paper 39332920Paper 39259591Paper 39207105Paper 39193906Paper 39127153Paper 39081315Paper 39028768Paper 39025270Paper 38902475Paper 38898085Paper 38896451Paper 38863869Paper 38778498Paper 38753503Paper 38717519Paper 38700353Paper 38699331Paper 38679747Paper 38657656Paper 38645169Paper 38643166Paper 38608634Paper 38597673Paper 38571760Paper 38565851Paper 38559037Paper 38477945Paper 38463959Paper 38458178Paper 38436133Paper 38405931Paper 38402617Paper 38400039Paper 38387080Paper 38352476Paper 38334805Trial NCT05016622Trial NCT04514484Trial NCT04401670Trial NCT03648983Trial NCT02774291Trial NCT02649569Trial NCT02578888Trial NCT02575872Trial NCT02527304Trial NCT02507076Trial NCT02382419Trial NCT02277561Trial NCT02112552Trial NCT02073968Trial NCT02038153Trial NCT02009436Trial NCT01958580Trial NCT01939210Trial NCT01899326Trial NCT01899261Trial NCT01897454Trial NCT01897441Trial NCT01857271Trial NCT01772420Trial NCT01697293Trial NCT01695941Trial NCT01605032Trial NCT01408160Trial NCT01367301Trial NCT01351909Trial NCT01319539Trial NCT01231906Trial NCT01145430Trial NCT01142401Trial NCT01061606Trial NCT01041027Trial NCT01001910Trial NCT00950365Trial NCT00470301Trial NCT00450944Trial NCT00437034Trial NCT00392353Trial NCT00324740Trial NCT00182767Trial NCT00179348Trial NCT00121251Trial NCT00096317Trial NCT00066638Trial NCT00057863Trial NCT00055692Trial NCT00030706Trial NCT00019474Trial NCT00004864Trial NCT00004863Trial NCT00003867Trial NCT00002461Patent 9671391Patent 7709613Patent 6821725Patent 6013468Patent 5876979

Abstract

PROJECT SUMMARY ? FLOW CYTOMETRY SHARED RESOURCE The Flow Cytometry Shared Resource of the Albert Einstein Cancer Center (AECC) was established in 1980 to provide investigators with convenient and affordable access to a broad spectrum of required analytical and preparative flow cytometry technologies. Over the subsequent nearly 40 years, the facility has expanded its dedicated laboratory space and staff, and added multiple new instruments and equipment upgrades. This growth has been enabled by continuous support from Cancer Center Support Grant, and generous input of funds and the College of Medicine. This facility furnishes AECC investigators with the majority of their on-site access to high speed fluorescence activated cell sorting (FACS) and advanced multiparameter flow cytometric analysis. The technologies provided are essential to the research of many AECC members, and cannot be outsourced or obtained at other sites in any practical or cost effective way. At present, the facility supports four high speed cell sorters, including two FACSAria sorters, and Beckman Coulter MoFlo XDP and Astrios EQ sorters. These three sorting platforms provide a high level of versatility, allowing optimization of protocols for isolation of rare and delicate cell types. The facility also provides access to a variety of analytical cytometers, which range from relatively simple and user friendly to advance analyzers such as the Becton-Dickinson LSR II with 14 color capability. Efforts are underway to add a new Cytek Aurora analyzer to the facility, which would further expand analytical capability to greater than 20 fluorescent parameters per cell. An iCys laser scanning cytometer is also housed and operated in the facility, providing a platform for coupled cytometric and image data collection on individual cells in a high throughput manner. The facility also provides biosafety containment for sorting cells from fresh human tissues. In addition to supporting an extensive range of advanced analytical and preparative flow cytometry equipment, the facility provides technical expertise and training to guide AECC investigators and their staff in the application of basic and advanced flow cytometry techniques. The facility also organizes and supports seminars and demonstrations of new technologies to assure that AECC investigators are well informed about newly emerging applications of FACS that can enhance their research. The overall goal of the facility is to provide the most up to date cell sorting and analytical resources for a wide range of cancer-relevant studies, and to deliver these in the most convenient and cost effective manner possible.

View original record on NIH RePORTER →